Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Wall Street, though, is clamoring for a rate cut, with an 85% chance of a move in July and a 61% probability of three reductions by year's end.The Fedread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
The flattening of the yield curve is exuding a bad omen for the stock market if history is any guide.Marketsread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Hong Kong Chief Executive Carrie Lam announced at a press conference on Saturday that a contentious bill to allow extraditions to mainland China has been put on hold.China Politicsread more
Stratolaunch, the world's largest airplane, which flew once, is up for sale, sources familiar told CNBC.Investing in Spaceread more
Transparency is key… or is it? With the first-ever non-transparent, actively managed exchange-traded fund receiving approval from the SEC, "ETF Edge" goes straight to the...ETF Edgeread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
A new update to the Apple Watch called watchOS 6 will notify you if the environment you're in is too loud and could damage your hearing.Technologyread more
(Adds details from trial testimony, PIX available)
May 29 (Reuters) - The father of a university football player who died of a drug overdose provided emotional testimony about the personal cost of the nationwide opioid epidemic on Wednesday during the second day of trial in a lawsuit by the
state of Oklahoma accusing drugmaker Johnson & Johnson
of fueling the crisis.
The testimony in a state court in Norman, Oklahoma, came during the first trial to result from more than 2,000 similar lawsuits against pharmaceutical manufacturers nationally seeking to hold them responsible for the opioid abuse crisis.
Those cases by state and local governments seek to hold the companies responsible for a drug abuse epidemic that the U.S. Centers for Disease Control and Prevention says led to a record 47,600 opioid-related overdose deaths in 2017.
Craig Box, an Oklahoma attorney, testified that he never suspected his son Austin was abusing prescription painkillers until after he was discovered unconscious at a friend's house in 2011 and was taken to a hospital.
Holding back tears, Box said he only learned after the death of the 22-year-old University of Oklahoma linebacker, who had a herniated disk the year before, that his son had once been prescribed opioids and must have turned to the streets to get more.
"We had no idea about the prevalence of these drugs and the dangers of these drugs," he said during testimony streamed online by Courtroom View Network.
Box was called as a witness to support claims by Oklahoma Attorney General Mike Hunter that J&J helped cause the epidemic by marketing opioids as safe and effective for everyday pain while downplaying their addictive qualities.
Hunter alleges that deceptive marketing campaigns carried out by J&J, along with OxyContin maker Purdue Pharma LP and Teva Pharmaceutical Industries Ltd, led to an oversupply of addictive painkillers in the state.
Oklahoma resolved its claims against Purdue in March for $270 million and against Teva on Sunday for $85 million, leaving J&J as the only defendant in the nonjury trial before Cleveland County District Judge Thad Balkman.
J&J denies wrongdoing, arguing that its marketing efforts were proper and that the state cannot prove it caused the opioid epidemic given the role doctors, patients, pharmacists and drug dealers played.
The state claims that J&J's actions created an oversupply of painkillers and a public nuisance that will cost $12.7 billion to $17.5 billion to remedy over the next 20 to 30 years. (Reporting by Nate Raymond in Boston Editing by Bill Berkrot)